11/14/2024
4:51 PM | Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Rubric Capital Management LP (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
5:57 PM | New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13D/A | |
11/06/2024
3:20 PM | Trevi Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
9:30 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
10/23/2024
1:44 PM | Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
10/21/2024
9:43 AM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/04/2024
7:07 AM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:00 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:54 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:37 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:55 PM | Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:10 PM | Meeker David P (Reporting)
Trevi Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
4:14 PM | SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Subject)
| Form 144/A | |
07/11/2024
4:52 PM | Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2024
3:16 PM | MAI Capital Management (Filed by)
Trevi Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
06/14/2024
3:40 PM | Mathers Edward T (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Colangelo Dominick (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Trevi Therapeutics (Issuer)
VANLENT ANNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Heffernan Michael Thomas (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Cassella James V (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:34 PM | New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13D/A | |
05/14/2024
3:51 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:09 PM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
6:39 PM | Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
03/20/2024
3:08 PM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:10 PM | Trevi Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2024
3:12 PM | Trevi Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/16/2024
3:42 PM | SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:43 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:43 PM | Clark David J (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:43 PM | Simon Farrell (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:44 PM | Galletta Christopher (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:42 PM | Delfini Lisa (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:47 PM | Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
2:48 PM | Fairmount Funds Management LLC (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
9:21 AM | Trevi Therapeutics (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Rubric Capital Management LP (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
